Judith Graham

Judith Graham was a contributing columnist for KFF Health News until January 2025.

Seniors With Prediabetes Should Eat Better, Get Moving, but Not Fret Too Much About Diabetes

About half of adults 65 and older have above-normal blood sugar levels that put them in the prediabetes category. Although that is a signal to improve your eating habits and get more exercise, researchers say only a small percentage of the group will develop diabetes.

¿Eres mayor y tienes síntomas de covid persistente? Esto es lo que deberías hacer

Pero hay que tener en cuenta que muchos médicos de atención primaria no saben cómo identificar y tratar covid persistente. Si tu médico no puede ayudarte, considera que te remita a un especialista que atienda a pacientes con covid a largo plazo. Además, ármate de paciencia: las esperas para las citas son largas.

‘That’s Just Part of Aging’: Long Covid Symptoms Are Often Overlooked in Seniors

Millions of older adults are grappling with long covid, yet the impact on them has received little attention even though research suggests seniors are more likely to develop the poorly understood condition than younger or middle-aged adults.

To Families’ Dismay, Biden Nursing Home Reform Doesn’t View Them as Essential Caregivers

Relatives who often provide vital caregiving for nursing home residents say the lockdowns during the covid pandemic showed the need for family members to visit in person with their loved ones. About a dozen states have passed laws guaranteeing that right, and California is considering one.

Despite Seniors’ Strong Desire to Age in Place, the Village Model Remains a Boutique Option

Membership-based villages help arrange services for seniors — such as handyman help or transportation to appointments — and provide social connections through classes, leisure opportunities, or community events. Despite great promise, they have been slow to expand because of difficulties raising funding and keeping people interested.

Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?

Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.